Wed, Aug 20, 2014, 8:36 AM EDT - U.S. Markets open in 54 mins.

Recent

% | $
Quotes you view appear here for quick access.

ArQule Inc. Message Board

  • stev_26_2000 stev_26_2000 Jan 11, 2012 9:34 PM Flag

    Arqule at 16th JFCR-ISCC January 25th and 26th

    News January 25th or 26th? Maybe Arqule will take the opportunity to announce the HCC results here at the 16th JFCR-ISCC conference. http://iscc.umin.jp/2011.html Two presentations that include ARQ-197 are as follows:

    1) Haruyasu Murakami (Shizuoka Cancer Center)

    The effect of CYP2C19 polymorphism on the tolerability of ARQ 197: Results from phase 1 trial in Japanese patients with metastatic solid tumors

    2) Brian Schwartz (Arqule Inc)

    Discovery and Development of Tivantinib, Non-ATP-Competitive Inhibitor Targeting MET Tyrosine Kinase for the Treatment of Solid Tumors.

    Steve

 
ARQL
1.31-0.03(-2.24%)Aug 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
TASER International Inc.
NasdaqGSTue, Aug 19, 2014 4:00 PM EDT
JA Solar Holdings Co., Ltd.
NasdaqGSTue, Aug 19, 2014 4:00 PM EDT